4.2 Article

High levels of blood glutamic acid and ornithine in children with intellectual disability

期刊

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/20473869.2020.1858520

关键词

aminoacidopathies; inborn errors of metabolism (IEMs); intellectual disability (ID); newborn screening (NBS); Pakistan

资金

  1. International Centre for Genetic Engineering and Biotechnology (ICGEB), Italy [CRP/PAK14-02, CRP/14/012]
  2. High Education Commission (HEC), Islamabad, Pakistan

向作者/读者索取更多资源

The objective of this study was to screen for aminoacidopathies in patients suspected of having inborn errors of metabolism. Abnormal amino acid profiles, particularly in glutamic acid, ornithine, and methionine levels, were found in some patients through biochemical analysis of samples. Advanced biochemical and genetic analyses confirmed these diseases and treatment could be offered to these patients, reducing the burden of intellectual disability caused by rare metabolic diseases in the target populations.
Objectives: Aminoacidopathies are inborn errors of metabolism (IEMs) that cause intellectual disability in children. Luckily, aminoacidopathies are potentially treatable, if diagnosed earlier in life. The focus of this study was the screening of aminoacidopathies in a cohort of patients suspected for IEMs. Methods: Blood samples from healthy (IQ > 90; n = 391) and intellectually disabled (IQ < 70; n = 409) children (suspected for IEMs) were collected from different areas of Northern Punjab, Pakistan. An analytical HPLC assay was used for the screening of plasma amino acids. Results: All the samples (n = 800) were analyzed on HPLC and forty-three out of 409 patient samples showed abnormal amino acid profiles mainly in the levels of glutamic acid, ornithine and methionine. Plasma concentration (Mean +/- SD ng/mL) were significantly high in 40 patients for glutamic acid (patients: 165 +/- 38 vs. controls: 57 +/- 8, p < 0.00001) and ornithine (patients: 3177 +/- 937 vs. controls: 1361 +/- 91, p < 0.0001). Moreover, 3 patients showed abnormally high (53.3 +/- 8.6 ng/mL) plasma levels of methionine. Conclusion: In conclusion, biochemical analysis of samples from such patients at the metabolites level could reveal the underlying diseases which could be confirmed through advanced biochemical and genetic analyses. Thus, treatment to some of such patients could be offered. Thus burden of intellectual disability caused by such rare metabolic diseases could be reduced from the target populations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据